OpenAccess: Closed

This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

Ralf Gutzmer,Anika Koop,Friedegund Meier,Jessica C. Hassel,Patrick Terheyden,Lisa Zimmer,Lucie Heinzerling,Selma Ugurel,Claudia Pföhler,Anja Gesierich,Elisabeth Livingstone,Imke Satzger,Katharina C. Kähler

Ipilimumab

Medicine

Autoimmunity

2017

Cite this:

Generate Citation

“Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity” is a paper by Ralf Gutzmer Anika Koop Friedegund Meier Jessica C. Hassel Patrick Terheyden Lisa Zimmer Lucie Heinzerling Selma Ugurel Claudia Pföhler Anja Gesierich Elisabeth Livingstone Imke Satzger Katharina C. Kähler published in 2017. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.